Counterpoint: Because some surrogate end point biomarkers measure the neoplastic process they will have high utility in the development of cancer chemopreventive agents against sporadic cancers.

Article

Counterpoint: Because some surrogate end point biomarkers measure the neoplastic process they will have high utility in the development of cancer chemopreventive agents against sporadic cancers.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jul 2003

Kelloff Gary J, O'Shaughnessy Joyce A, Gordon Gary B, Hawk Ernest T, Sigman Caroline C

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Approval

Share to Drug Design

Share to Precancerous Conditions

Share to Predictive Value of Tests

Share to Reproducibility of Results

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

Counterpoint: Because some surrogate end point biomarkers measure the neoplastic process they will have high utility in the development of cancer chemopreventive agents against sporadic cancers.PMID 12869396Read

Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials.Semantic proximity Read

Intraepithelial neoplasia, surrogate endpoint biomarkers, and cancer chemoprevention.Semantic proximity Read

Chemoprevention: general perspective.Semantic proximity Read

General mechanisms of carcinogenesis and anticarcinogenesis.Semantic proximity Read

Multiple points of intervention in the prevention of cancer and other mutation-related diseases.Semantic proximity Read

Folate and cancer prevention--where to next? Counterpoint.Semantic proximity Read

[Carcinogenesis].Semantic proximity Read

Overview of mechanisms of cancer chemopreventive agents.Semantic proximity Read